| | | | | | | | From formulation development through commercial production, drugmakers require analytics that can adapt to the changing needs of the industry. Flexible analytics platforms that can handle discrete, infrequent lab data at the R&D scale must evolve with manufactured products to gather data across hundreds of reactors at the production scale. Empowering engineers to streamline common workflows across each phase of the drug product life cycle will allow for cost reduction and time improvements. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Learn how the Good Manufacturing Practices Annex 1 revisions for sterile drug products will have implications for pharmaceutical companies that market their sterile drug products in the EU, whether manufactured in the U.S or elsewhere in the world. |
|
|
|
| |
| | |
|
|
| | | | | The biotech also said that it will be exploring non-dilutive funding options and potential partnerships for various assets. |
|
|
| Novartis will license a histone deacetylase 6 (HDAC6) inhibitor currently in phase 1 trials for Charcot-Marie-Tooth disease. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | Scaling up requires choosing the optimal media formulations, securing reliable supply chains, and maintaining product quality, all while remaining cost-effective. This article outlines five top media-related factors to consider to help you achieve success. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
